Journals / Anadolu Kardiyoloji Dergisi / 2005 / Cilt: 5 - Sayı: 4

QT prolongation and ventricular tachycardia due to roxithromycin

Roksitromisin kullanımına bağlı gelişen QT uzaması ve ventriküler taşikardi

Pages
319–321
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

GÜROL, T., SAYALI, E., EKİZOĞLU, İ., TEMELOĞLU, E., KESKİN, S. (2022). QT prolongation and ventricular tachycardia due to roxithromycin. Anadolu Kardiyoloji Dergisi, Cilt: 5 - Sayı: 4, 319–321. https://ajindex.com/articles/437384

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Gök H. Klinik Kardiyoloji. 2. baskı. Konya: Nobel Tıp Kitapevleri; 2002
  2. Crouch MA, Limon L, Cassano AT. Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy 2003; 21: 881-908
  3. Promphan W, Khongphatthanayothin A, Horchaiprasit K, Benjacholamas V. Roxithromycin induced torsade de pointes in a patient with complex congenital heart disease and complete atrioventricular block. Pacing Clin Electrophysiol 2003; 26: 1424-6
  4. Haffner S, Lapp H, Thurmann PA. Adverse drug reactions-case report. Dtsch Med Wochenschr 2002; 127: 1021
  5. Volberg WA, Koci BJ, Su W, Lin J, Zhou J. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320-7
  6. Woywodt A, Grommas U, Buth W, Rafflenbeul W. QT prolongation due to roxithromycin. Postgrad Med J 2000; 76: 651-3
  7. Akar N, Aydoğdu S, Diker E. Ventriküler aritmilere genel yaklaşım. Anadolu Kardiyol Derg 2004; 3: 246-52.